Overview

Effect of Intraventricular tPA Following Aneurysmal Subarachnoid Hemorrhage

Status:
Withdrawn
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the hypothesis that the administration of intraventricular tPA reduces the rates of cerebral vasospasm and ventriculoperitoneal shunt-dependent hydrocephalus in patients with aneurysmal subarachnoid hemorrhage.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Rush University Medical Center
Treatments:
Plasminogen
Tissue Plasminogen Activator